參考文獻/References:
[1] Firestein GS,McInnes IB.Immunopathogenesis of rheumatoid arthritis[J].Immunity,2017,46(2):183-196.
[2] 葉天士.臨證指南醫案[M].北京:北京科學技術出版社,2014:294.
[3] 朱竹菁,蘇 勵,田 雨.蠲痹化濕湯治療女性寒濕型類風濕關節炎臨床研究[J].陜西中醫,2020,41(5):632-635.
[4] Jekic B,Maksimovic N,Damnjanovic T.Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis[J].Pharmacogenomics,2019,20(17):1235-1245.
[5] 朱田田,趙中亭,趙怡坤,等.艾灸對類風濕關節炎炎性損傷修復機制的現代研究進展[J].針刺研究,2017,42(3):271-274.
[6] 李光輝,張軍平,丁 義,等.四妙勇安湯抑制血管內皮細胞P-選擇素、NF-κB表達的實驗研究[J].中華中醫藥學刊,2017,35(8):2058-2060.
[7] 國家食品藥品監督管理總局.中藥新藥臨床研究指導原則[S].北京:中國醫藥科技出版社,2002:115-119.
[8] 中華醫學會風濕病學分會.類風濕關節炎診治指南(草案)[J].中華風濕病學雜志,2003,17(4):250-254.
[9] 傅麗暉,張 瑾,梁 良.MRI動態增強技術對活動性類風濕性關節炎療效判斷的應用價值[J].醫學影像學雜志,2019,29(5):828-832.
[10] 鮑嘉敏,宋永嘉,陳錦漫,等.自我管理對類風濕性關節炎患者疼痛緩解的效果評價:Meta分析和系統評價[J].世界中醫藥,2020,15(7):89-96.
[11] McWilliams DF,Walsh DA.Pain mechanisms in rheumatoid arthritis[J].Clin Exp Rheumatol,2017,35(5):94-101.
[12] McGonagle D,Watad A,Savic S.Mechanistic immunological based classification of rheumatoid arthritis[J].Autoimmun Rev,2018,17(11):1115-1123.
[13] 盧文藝,周祖山,周艷華,等.周祖山教授分期辨治類風濕關節炎經驗探析[J].中醫藥信息,2019,36(1):62-65.
[14] Aletaha D,Smolen JS.Diagnosis and management of rheumatoid arthritis:A review[J].JAMA,2018,320(13):1360-1372.
[15] Uneda A,Hirashita K,Kanda T,et al.Primary central nervous system methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis:Case report and review of literature[J].NMC Case Rep Journal,2020,7(3):121-127.
[16] 王瑞萍.類風濕關節炎患者血清中抗CCP抗體和TNF-α表達的臨床意義[J].重慶醫學,2017,12(46):46-47,50.
[17] 徐士榮,徐 駿,徐紅珍,等.RF抗CCP抗體,抗AKA及CRP聯合檢測在類風濕關節炎診斷中的應用價值[J].檢驗醫學與臨床,2020,17(2):61-63.
[18] 高學祥,汪六慶.血清抗CCP抗體、RF、CRP、ESR水平聯合檢測在類風濕性關節炎患者早期診斷中的應用價值[J].檢驗醫學與臨床,2018,15(14):2156-2159.
[19] 孫 莉,王曉非.血常規指標判斷類風濕關節炎活動性意義的研究進展[J].山東醫藥,2019,59(2):110-112.
[20] 劉昌蓮,賀冬冬,李曉明,等.艾拉莫德治療類風濕關節炎療效及對患者免疫炎癥因子水平和骨代謝指標的影響[J].陜西醫學雜志,2020,49(5):603-607.
[21] 申 丹,楊衛彬,王曉曼.血小板與類風濕關節炎中醫證候相關性初探[J].世界中醫藥,2016,11(8):1640-1643.
相似文獻/References:
[1]程紅衛,秦 艷,胡筱娟.青白通痹膠囊的組方學研究*[J].陜西中醫雜志,2019,(4):537.
[2]全 健,丁文濤 Δ,武 輝.穴位注射配合桂枝芍藥知母湯加減治療類風濕性關節炎臨床研究[J].陜西中醫雜志,2019,(5):671.
QUAN Jian,DING Wentao,WU Hui..Rheumatoid arthritis treated by acupoint injection combined with Guizhi Shaoyao Zhimu decoction[J].,2019,(3):671.
[3]戴鳳翔,邱聯群△.當歸四逆湯聯合灸法治療類風濕性關節炎臨床研究[J].陜西中醫雜志,2019,(9):1235.
[4]劉 茜,張翊一,李映雪△,等.川羌除痹湯聯合西藥對類風濕性關節炎患者免疫功能及Th1/Th2型細胞因子的影響[J].陜西中醫雜志,2019,(12):1732.
LIU Qian,ZHANG Yiyi,LI Yingxue,et al.Effects of Chuanqiang Chubi decoction and western medicine on immune function and Th1/Th2 cytokines in patients with rheumatoid arthritis[J].,2019,(3):1732.
[5]張 娜,唐華燕.生地苦參湯聯合艾拉莫德對類風濕性關節炎患者血清抗CCP抗體及炎癥因子的影響[J].陜西中醫雜志,2022,(3):318.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.011]
ZHANG Na,TANG Huayan.Effect of Shengdi Kushen decoction combined with iguratimod on serum anti CCP antibody and inflammatory factors in rheumatoid arthritis[J].,2022,(3):318.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.011]